Biogen
BIIB
$300.20
Share price
-0.73%
Change (1 day)
49.64%
Change (1 year)
Categories
Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.
Biogen (BIIB) - Total assets
Total assets on the balance sheet as of March 2023 : $24.59 B
According to Biogen's latest financial reports the company's total assets are $24.59 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Biogen - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $24.55 B | 2.83% |
| 2021-12-31 | $23.87 B | -3.01% |
| 2020-12-31 | $24.61 B | -9.6% |
| 2019-12-31 | $27.23 B | 7.69% |
| 2018-12-31 | $25.28 B | 6.92% |
| 2017-12-31 | $23.65 B | 3.39% |
| 2016-12-31 | $22.87 B | 17.29% |
| 2015-12-31 | $19.50 B | 36.24% |
| 2014-12-31 | $14.31 B | 20.68% |
| 2013-12-31 | $11.86 B | 17.11% |
| 2012-12-31 | $10.13 B | 11.94% |
| 2011-12-31 | $9.04 B | 11.83% |
| 2010-12-31 | $8.09 B | -5.37% |
| 2009-12-31 | $8.55 B | 0.86% |
| 2008-12-31 | $8.47 B | -1.74% |
| 2007-12-31 | $8.62 B | 0.89% |
| 2006-12-31 | $8.55 B | 2.22% |
| 2005-12-31 | $8.36 B | -8.72% |
| 2004-12-31 | $9.16 B | -3.56% |
| 2003-12-31 | $9.50 B | 373.54% |
| 2002-12-31 | $2.00 B | 16.61% |
| 2001-12-31 | $1.72 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $187.37 B | 661.75% | 🇺🇸 USA |
 Pfizer PFE | $197.20 B | 701.70% | 🇺🇸 USA |
 AbbVie ABBV | $138.80 B | 464.28% | 🇺🇸 USA |
 Amgen AMGN | $88.72 B | 260.67% | 🇺🇸 USA |
 Sanofi SNY | $135.71 B | 451.73% | 🇫🇷 France |
 Gilead Sciences GILD | $61.87 B | 151.54% | 🇺🇸 USA |
 Illumina ILMN | $11.81 B | -51.98% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.39 B | -98.39% | 🇺🇸 USA |
 Qiagen QGEN | $6.28 B | -74.44% | 🇳🇱 Netherlands |
 Bio-Rad Laboratories BIO | $13.50 B | -45.11% | 🇺🇸 USA |